This variant has been described several times, and although the role of GALNT12 in familial cancer is controversial, this particular variant most likely confers a moderate risk (Guda et al., 2009; Clarke et al., 2012; Seguí et al., 2014; Lorca et al., 2017; Evans et al., 2018). The gene discussed is GALNT12; the disease is hereditary cancer.